Limits availability and coverage for non-invasive prenatal testing for Medicaid patients based on age if such limits are recommended by the United States food and drug administration, the centers for Medicare and Medicaid services, or the United States department of health and human services.
Requires the recommendation to a parent for blood lead level screenings of his or her child when a health care provider finds high lead levels in the blood of such child; directs the department of health to conduct an environmental investigation when a child is found to have high levels of lead in his or her blood.
Establishes a pregnant persons' bill of rights; requires posting and disclosing such bill of rights; establishes a penalty for failure to post or disclose such bill of rights.
Relates to notification changes to the model contract with managed care providers under the medical assistance program; requires the department to post on its website certain changes required to be submitted to the centers for medicare and medicaid.
Relates to definitions of certain terms relating to the NYS medical indemnity fund; repeals certain provisions relating to claims for qualifying health care costs under the NYS medical indemnity fund; and relates to the effectiveness of certain provisions relating to the NYS medical indemnity fund.
Directs the commissioner of health and the commissioner of the office for people with developmental disabilities to conduct a study of the delivery of services to individuals with traumatic brain injury.
Relates to availability of certain reports detailing sales of opioids in this state; excludes the name, address and DEA registration number of the entity to whom the opioid was sold from such publication.
Requires medical assistance be provided to victims of domestic violence to care for and treat any scarring resulting from the domestic violence incident.
Includes pain management medications that the decedent was prescribed, such as gabapentin, on a death certificate where a death is caused by an opioid overdose.
Requires managed care providers that provide coverage for prescription drugs to provide coverage for home delivery of any covered prescription by any non-mail-order retail pharmacy in the managed care provider network.